Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
2002 • 6,825 citations
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
1994 • 3,408 citations
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
1994 • 2,993 citations
CYCLOOXYGENASES 1 AND 2
1998 • 2,700 citations
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
2002 • 1,963 citations
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
1993 • 1,655 citations
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
1999 • 1,488 citations
The way I see it: House officers need formal career development
2002 • 1,137 citations
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
2002 • 1,054 citations
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
2001 • 832 citations
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets
2002 • 319 citations
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S. Circulation 2002; 105: 1650- 1655.
2002 • 303 citations
Kinetic basis for selective inhibition of cyclo-oxygenases
1999 • 272 citations
Molecular and Transcriptional Regulation of Megakaryocyte Differentiation
2001 • 175 citations
Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers
2001 • 172 citations
Towards a definition of aspirin resistance: a typological approach
2002 • 162 citations
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass
1999 • 153 citations
Variability in the Pharmacokinetics and Pharmacodynamics of Low Dose Aspirin in Healthy Male Volunteers
1995 • 140 citations
Aspirin resistance after coronary artery bypass grafting
2001 • 103 citations
Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues.
2000 • 91 citations
Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil–induced myelotoxicity in mice
1999 • 69 citations
Flow cytometry analysis of platelet cyclooxygenase‐2 expression: induction of platelet cyclooxygenase‐2 in patients undergoing coronary artery bypass grafting
2002 • 59 citations
Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system
1988 • 56 citations
Coagulation, Fibrinolysis and Platelet P-selectin Expression in Peripheral Vascular Disease
2001 • 40 citations
Habitual smoking causes an abnormality in platelet thromboxane A 2 metabolism and results in an altered susceptibility to aspirin effects
2000 • 40 citations
Effects of terbogrel on platelet function and prostaglandin endoperoxide transfer
1998 • 17 citations
Kinetics of Aspirin Absorption Following Oral Administration of Six Aqueous Solutions with Different Buffer Capacities
1984 • 8 citations